Department of Pharmacology, Pharmacotherapy and Toxicology Faculty of Pharmacy, Medical University of Sofia, 2 Dunav St., 1000 Sofia, Bulgaria.
Department of Pharmacognosy, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav St., 1000 Sofia, Bulgaria.
Phytomedicine. 2016 May 15;23(5):483-90. doi: 10.1016/j.phymed.2016.02.024. Epub 2016 Mar 8.
Diabetes and hypertension are diseases that often coexist, which increases the risk of chronic organ damages and cardiovascular complications.
To evaluate the effects of saponarin, isolated from Gypsophila trichotoma Wend, on blood pressure, glycemia, body weight, and liver biochemical parameters related to oxidative stress in diabetic normotensive Wistar Kyoto rats (NTR) and spontaneously hypertensive rats (SHR).
Diabetes was induced by administration of streptozotocin (40 mg/kg, i.p.). The following biochemical parameters: reduced glutathione (GSH), malondialdehyde (MDA), total cytochrome P450, aniline hydroxylase (AH) activity, as well as the activities of antioxidant enzymes such as glutathione peroxidase (GPx), glutathione reductase (GR) and glutathione S-transferase (GST) were measured in the livers of euthanized rats.
Saponarin exerted slight antihypertensive activity in non-diabetic SHR, judged by 19% (p<0.05) decrease of the initial blood pressure. However, such effect was not observed in streptozotocin-induced diabetic SHR (SHR-D). Streptozotocin-induced diabetes was evidenced by 78% (p<0.05) and by 171% (p<0.05) increase in blood glucose level in NTR and SHR, respectively. In non-diabetic SHR the initial MDA quantity was by 36% (p<0.05) higher and the initial GSH levels were by 28% (p<0.05) lower in comparison to non-diabetic NTR. Significant decrease in the activities of GPx, GR, and GST was measured in the livers of all diabetic rats. Treatment with saponarin ameliorated the above mentioned liver parameters in both diabetic strains, however its effects were less pronounced in the diabetic SHR group.
Taken together our data indicate that diabetes and hypertension in combination are more difficult to be modulated by saponarin.
糖尿病和高血压是经常同时存在的疾病,这增加了慢性器官损伤和心血管并发症的风险。
评估从婆婆纳属植物中分离得到的瑞香苷对血压、血糖、体重和与氧化应激相关的肝生化参数的影响,在糖尿病正常血压 Wistar 京都大鼠(NTR)和自发性高血压大鼠(SHR)中。
通过链脲佐菌素(40mg/kg,ip)诱导糖尿病。测量安乐死大鼠肝脏中的还原型谷胱甘肽(GSH)、丙二醛(MDA)、总细胞色素 P450、苯胺羟化酶(AH)活性以及谷胱甘肽过氧化物酶(GPx)、谷胱甘肽还原酶(GR)和谷胱甘肽 S-转移酶(GST)等抗氧化酶的活性。
瑞香苷对非糖尿病 SHR 有轻微的降压作用,表现为初始血压降低 19%(p<0.05)。然而,在链脲佐菌素诱导的糖尿病 SHR(SHR-D)中未观察到这种作用。链脲佐菌素诱导的糖尿病导致 NTR 和 SHR 的血糖水平分别升高 78%(p<0.05)和 171%(p<0.05)。与非糖尿病 NTR 相比,非糖尿病 SHR 的初始 MDA 量增加了 36%(p<0.05),初始 GSH 水平降低了 28%(p<0.05)。所有糖尿病大鼠的肝组织中 GPx、GR 和 GST 的活性均显著降低。用瑞香苷治疗可改善两种糖尿病大鼠的上述肝参数,但在糖尿病 SHR 组的效果不明显。
总的来说,我们的数据表明,糖尿病和高血压同时存在时,瑞香苷更难调节。